Engineered immune cells show promise for long-term HIV suppression

A new study suggests a single infusion of engineered immune cells may suppress HIV for years, with two patients achieving undetectable viral levels. This gene therapy approach, similar to successful blood cancer treatments, modifies a patient's own cells to target and control the virus. One participant has remained suppressed for nearly two years. The research, presented at a gene therapy conference, offers a potential "proof of concept" for a one-time HIV treatment, though widespread availability is still many years away.